Viewing Study NCT05460195


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2025-12-31 @ 3:06 AM
Study NCT ID: NCT05460195
Status: UNKNOWN
Last Update Posted: 2022-07-15
First Post: 2022-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation
Sponsor: Shanghai Chest Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module